Showing 8 of 8 recruiting trials for “Proximal myotonic myopathy”
An Open-Label Extension Study to Evaluate the Long-Term Safety and Efficacy of Once Daily Mexiletine PR in Patients With Myotonic Dystrophy Type 1 and Type 2 Who Have Completed MEX-DM-302 Study.
A Study to Investigate the Safety, Tolerability, and Efficacy of SAR446268, an Adeno-associated Viral Vector-mediated Gene Therapy in Participants Aged 10 to 50 Years of Age With Non-congenital Myotonic Dystrophy Type 1
Investigating Exercise in Myotonic Dystrophy Type 2 (DM2)
The Efficacy and Safety of Once Daily Mexiletine PR in Patients With Myotonic Dystrophy Type 1 and Type 2
RecruitingNCT05854433 ↗
Brain Structure and Clinical Endpoints in Myotonic Dystrophy Type 2
👨⚕️ Araya Puwanant, MD, MS, Wake Forest University Health Sciences📍 1 site📅 Started Apr 2023View details ↗
RecruitingNCT04003363 ↗
The United Kingdom National Registry for Myotonic Dystrophy
👨⚕️ Chiara Marini-Bettolo, MD, PhD, John Walton Muscular Dystrophy Research Centre📍 1 site📅 Started May 2013View details ↗
RecruitingNCT02398786 ↗
Myotonic Dystrophy Family Registry
👨⚕️ Tanya Stevenson, EdD, MPH, Myotonic Dystrophy Foundation📍 1 site📅 Started Feb 2013View details ↗
RecruitingNCT00082108 ↗
Myotonic Dystrophy and Facioscapulohumeral Muscular Dystrophy Registry
👨⚕️ Johann Hamel, MD, University of Rochester Medical Center, Department of Neurology📍 1 site📅 Started Sep 2000View details ↗
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →